BRILIQUE receives a positive preliminary medical benefit assessment
- Details
- Category: AstraZeneca
AstraZeneca today announced that the German reimbursement body, the Federal Joint Committee (G-BA), has published the Institute for Quality and Efficiency in Healthcare (IQWiG) preliminary assessment report regarding the medical benefit of BRILIQUE (ticagrelor).
Merck Publishes 2010 Global Corporate Responsibility Report
- Details
- Category: Merck
Merck (NYSE: MRK), known as MSD outside the United States and Canada, launched its 2010 global corporate responsibility report, which emphasizes the importance of discovering better ways of doing business to benefit both society and its business.
Takeda completes acquisition and names new CEO of Nycomed
- Details
- Category: Takeda
Takeda Pharmaceutical Company Limited ("Takeda", TSE: 4502) announced it has completed its acquisition of Nycomed A/S ("Nycomed") for 9.6 billion Euro on a cash-free, debt-free basis and made Nycomed a wholly owned subsidiary of Takeda effective the same day.
NABP and Pfizer Partner to Educate Patients About The Flood of Counterfeit Medicines Online
- Details
- Category: Pfizer
Pfizer Inc. (NYSE: PFE) and the National Association of Boards of Pharmacy® (NABP) are launching a new effort to draw attention to the risks associated with counterfeit prescription medicines and help patients learn how to safely buy medicines online.
Lilly Launches Open Innovation Drug Discovery Platform
- Details
- Category: Eli Lilly and Company
Eli Lilly and Company (NYSE: LLY) announced the launch of a new open innovation platform designed to help build the company's pipeline of tomorrow and, from a philanthropic perspective, identify molecules that may have application for treating multi-drug resistant tuberculosis (MDR-TB).
Merck publishes innovation brochure with interactive features
- Details
- Category: Merck Group
Merck KGaA announced today that it has published a new brochure depicting how the company successfully transforms new ideas into innovative products, services and processes. The brochure concisely presents Merck innovations in pharmaceuticals, chemicals and life sciences that help to improve quality of life.
Sanofi successfully prices USD 1 billion bond issue
- Details
- Category: Sanofi
Sanofi (EURONEXT: SAN and NYSE: SNY) announces that it has successfully priced its offering of USD 1 billion of notes denominated in US dollars, due 2014, bearing interest at an annual rate of 1.20%.
More Pharma News ...
- New Novartis data show potential of respiratory portfolio
- Roche's investigational medicine T-DM1 shows improvement in progression-free survival
- New Data from Phase III IMPRES Clinical Trial
- Boehringer Ingelheim enrols first patient in TOviTO Phase III clinical trial program
- Bristol-Myers Squibb and Ambrx Announce Collaboration
- Sanofi Pasteur Donates Vaccine Strain Used for Polio Eradication to WHO
- Bristol-Myers Squibb and Ono Enter into Strategic Agreement